FIT Biotech supports the realisation of its strategic and business objectives and secures its business continuity in changing circumstances through risk management. The capability to take risks and manage them efficiently is crucial to business success and the creation of shareholder value.
FIT Biotech’s internal control and risk management follow that the company operates efficiently, the information it publishes is up to date and reliable, and all existing regulation is followed.
The Board of Directors has the principal responsibility for overseeing accounting and asset management. The financial position of FIT Biotech and its development are followed monthly by the management team and the Board of Directors. The information is published in accordance with the company’s communication policy.